Suppr超能文献

新兴 SARS-CoV-2 变体 B.1.1.529 的刺突糖蛋白的功能特性。

Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529.

机构信息

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology, Harvard Medical School, Boston, MA 02215, USA.

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Department of Microbiology, Harvard Medical School, Boston, MA 02215, USA.

出版信息

Cell Rep. 2022 Jun 14;39(11):110924. doi: 10.1016/j.celrep.2022.110924. Epub 2022 May 20.

Abstract

The recently emerged B.1.1.529 (Omicron) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant has a highly divergent spike (S) glycoprotein. We compared the functional properties of B.1.1.529 BA.1 S with those of previous globally prevalent SARS-CoV-2 variants, D614G and B.1.617.2. Relative to these variants, B.1.1.529 S exhibits decreases in processing, syncytium formation, virion incorporation, and ability to mediate infection of cells with high TMPRSS2 expression. B.1.1.529 and B.1.617.2 S glycoproteins bind ACE2 with higher affinity than D614G S. The unliganded B.1.1.529 S trimer is less stable at low temperatures than the other SARS-CoV-2 Ss, a property related to its more "open" S conformation. Upon ACE2 binding, the B.1.1.529 S trimer sheds S1 at 37°C, but not at 0°C. B.1.1.529 pseudoviruses are relatively resistant to neutralization by sera from patients with coronavirus disease 2019 (COVID-19) and vaccinees. These properties of the B.1.1.529 S glycoprotein likely influence the transmission, cytopathic effects, and immune evasion of this emerging variant.

摘要

最近出现的 B.1.1.529(奥密克戎)严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)变体具有高度分化的刺突(S)糖蛋白。我们比较了 B.1.1.529 BA.1 S 与之前全球流行的 SARS-CoV-2 变体 D614G 和 B.1.617.2 的功能特性。与这些变体相比,B.1.1.529 S 的加工、合胞体形成、病毒粒子掺入以及介导高 TMPRSS2 表达细胞感染的能力降低。B.1.1.529 和 B.1.617.2 S 糖蛋白与 ACE2 的结合亲和力高于 D614G S。未结合的 B.1.1.529 S 三聚体在低温下比其他 SARS-CoV-2 S 更不稳定,这种特性与其更“开放”的 S 构象有关。在 ACE2 结合后,B.1.1.529 S 三聚体在 37°C 下但不在 0°C 下脱落 S1。B.1.1.529 假病毒对来自 2019 年冠状病毒病(COVID-19)患者和疫苗接种者的血清的中和作用具有相对抗性。B.1.1.529 S 糖蛋白的这些特性可能影响这种新兴变体的传播、细胞病变效应和免疫逃逸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/9119962/63698a65e652/fx1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验